21:17 EST Cathie Wood’s ARK Investment buys 291K shares of Beam Therapeutics (BEAM) today
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics price target raised to $37 from $34 at Clear Street
- Cathie Wood Steps Up Bet on Bullish Stock (BLSH), Trims Stake in Palantir (PLTR) amid Strong Q3 Earnings
- Beam Therapeutics reports Q3 EPS ($1.10), consensus ($1.03)
- Promising Potential of BEAM-101 in Sickle Cell Treatment Justifies Buy Rating
- Cathie Wood’s ARK Investment buys 336K shares of Beam Therapeutics today